1. Home
  2. RLAY vs LGIH Comparison

RLAY vs LGIH Comparison

Compare RLAY & LGIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$7.82

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo LGI Homes Inc.

LGIH

LGI Homes Inc.

HOLD

Current Price

$51.69

Market Cap

1.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLAY
LGIH
Founded
2015
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
RLAY
LGIH
Price
$7.82
$51.69
Analyst Decision
Strong Buy
Hold
Analyst Count
9
5
Target Price
$16.00
$71.13
AVG Volume (30 Days)
2.3M
401.2K
Earning Date
11-06-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
4.53
Revenue
$8,355,000.00
$1,788,933,000.00
Revenue This Year
$27.30
N/A
Revenue Next Year
$7.43
$15.95
P/E Ratio
N/A
$11.47
Revenue Growth
N/A
N/A
52 Week Low
$1.78
$39.70
52 Week High
$8.36
$112.97

Technical Indicators

Market Signals
Indicator
RLAY
LGIH
Relative Strength Index (RSI) 64.31 59.56
Support Level $6.28 $43.17
Resistance Level $8.36 $53.64
Average True Range (ATR) 0.50 2.40
MACD 0.14 0.87
Stochastic Oscillator 76.56 81.28

Price Performance

Historical Comparison
RLAY
LGIH

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About LGIH LGI Homes Inc.

LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. The company have seven operating segments ( West, Northwest, Central, Midwest, Florida, Southeast and Mid-Atlantic) that it aggregates into five qualifying reportable segment. Majority of the revenue is generated from Central division segment.

Share on Social Networks: